180mg of ETC-1002(bempedoic acid)

DRUG3 trials

Sponsors

Otsuka Pharmaceutical Co., Ltd.

Conditions

Hyper-low-density Lipoprotein (LDL) CholesterolemiaHypercholesterolemia

Phase 2

A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia

CompletedNCT04784442

Otsuka Pharmaceutical Co., Ltd.Hypercholesterolemia

Start: 2021-03-24End: 2022-05-17Updated: 2024-05-10

Phase 3

A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia

CompletedNCT05683340

Otsuka Pharmaceutical Co., Ltd.Hyper-low-density Lipoprotein (LDL) Cholesterolemia

Start: 2023-02-13End: 2024-03-12Updated: 2025-03-13

A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia

CompletedNCT05687071

Otsuka Pharmaceutical Co., Ltd.Hyper-low-density Lipoprotein (LDL) Cholesterolemia

Start: 2023-02-27End: 2024-11-02Updated: 2026-02-20